Strategies for targeting the DNA damage response for cancer therapeutics.

about

Role of AKT signaling in DNA repair and clinical response to cancer therapy.Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance.

P2860

Q34193741-D050DE92-3F4C-43D1-8092-C5512B015DE3 Q47116087-07308978-48EB-4F9A-8B77-64FB400B40EA

P2860

Strategies for targeting the DNA damage response for cancer therapeutics.

Item

http://www.wikidata.org/entity/Q42637891

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Strategies for targeting the DNA damage response for cancer therapeutics.

@en

Strategies for targeting the DNA damage response for cancer therapeutics.

@nl

type

Item

label

Strategies for targeting the DNA damage response for cancer therapeutics.

@en

Strategies for targeting the DNA damage response for cancer therapeutics.

@nl

prefLabel

Strategies for targeting the DNA damage response for cancer therapeutics.

@en

Strategies for targeting the DNA damage response for cancer therapeutics.

@nl

P1476

Strategies for targeting the DNA damage response for cancer therapeutics.

@en

P2093

Bo Xu

http://www.w3.org/2001/XMLSchema#string

Dan Zhang

http://www.w3.org/2001/XMLSchema#string

Hai-Bo Wang

http://www.w3.org/2001/XMLSchema#string

Kathryn L Brinkman

http://www.w3.org/2001/XMLSchema#string

Su-Xia Han

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

The DNA-damage response in human biology and disease

Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

PARP inhibitors stumble in breast cancer

The DNA damage response: ten years after

The concept of synthetic lethality in the context of anticancer therapy

Cell-cycle checkpoints and cancer

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

P304

359-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

editorial

P356

10.5732/CJC.012.10087

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2012-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227166952

http://www.w3.org/2001/XMLSchema#string

P698

22704491

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

DNA damage

P932

3777509

http://www.w3.org/2001/XMLSchema#string

Strategies for targeting the DNA damage response for cancer therapeutics.

about

P2860

P2860

Strategies for targeting the DNA damage response for cancer therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P5875

P698

P921

P932